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as well as immunological markers were negative. 
On the basis of electroencephalography and head 
computed tomography (CT), the patient was di‑
agnosed with nonconvulsive epilepsy (treated 
with valproic acid). An abdominal CT scan re‑
vealed polysplenia (FIGURE 1A) and the absence of 
the portal vein (FIGURE 1B). It also showed that 
the splenic and intestinal venous blood flowed 
via the splenic and mesenteric veins to the in‑
ferior vena cava and to the left renal vein with‑
out passing through the liver (FIGURE 1C). On por‑
tovenography with the occlusion test (FIGURE 1D), 
the liver was not perfused with portal blood and 
the superior mesenteric vein and splenic vein did 
not join to form confluence (abernethy malfor‑
mation type IB).
A 31 ‑year ‑old male patient with chronic membra‑
noproliferative glomerulonephritis (confirmed 
by biopsy) treated with immunosuppression 
(steroids, cyclosporine, mycophenolate mofetil) 
was admitted to the hospital due to nephrotic 
syndrome with chronic kidney disease stage 3 
and coma (rigid pupils with bilateral Babinski 
sign). Blood tests revealed elevated concentra‑
tions of ammonia (288 µmol/l), serum creati‑
nine (258 µmol/l), urea (31.2 mmol/l), serum 
albumin (27 g/l), alanine aminotransferase (37 
U/l), aspartate aminotransferase (30 U/l), biliru‑
bin (24 µmol/l), γ‑glutamyltranspeptidase (138 
U/l), cholinesterase (3678 U/l), ceruloplasmin 
(0.26 g/l), and alkaline phosphatase (205 U/l). Se‑
rological markers for hepatitis A, B, C, G viruses, 
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FIGURE 1 A – computed tomography scan: multiple spleens (white arrow); B – computed tomography scan: absence 
of the portal vein (white arrow); C – computed tomography scan: splenic vein (white arrow) and inferior mesenteric vein 
(short black arrow) connect with the left renal vein (long blue arrow) to form a common confluence (short blue arrow) 
entering the inferior vena cava (long black arrow); D – image showing no contrast enhancement of the portal vein
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The congenital absence of the portal vein is 
a very rare portal venous blood system malforma‑
tion that has been reported in 101 patients since 
1793 (first described by John Abernethy). In this 
malformation, splanchnic venous blood partial‑
ly or completely bypasses the liver and drains di‑
rectly into the inferior vena cava or to the left re‑
nal vein as a result of the congenital absence of 
the portal vein or the hypoplastic portal vein.1
The CAPV is frequently associated with oth‑
er congenital cardiac, gastrointestinal, genitouri‑
nary, or skeletal defects. The lack of portal flow 
can result in the development of nodular regen‑
erative hyperplasia or hepatocellular adenoma, 
rarely hepatocellular carcinoma or hepatoblas‑
toma.2 Portosystemic encephalopathy is rare in 
patients with congenital absence of the portal 
vein, and it is more common in older patients 
because of increased brain sensitivity to ammo‑
nia or disorders of homeostatic control mech‑
anisms that develop with aging. A serious al‑
though rare complication may be hepatopulmo‑
nary syndrome due to humoral factors (in nor‑
mal conditions metabolized by the portal passage 
through the liver) shunted into the systemic and 
pulmonary venous circulation.3,4
Six months later, the patient was started on 
hemodialysis due to exacerbation of chronic kid‑
ney disease (serum creatinine, 720 µmol/l; urea, 
33 mmol/l). A dialysis regimen with 4 sessions 
per week was introduced along with protein re‑
striction (0.6 g/kg/d), with administration of in‑
travenous aminoacids and albumin supplemen‑
tation twice a month. The patient’s clinical con‑
dition significantly improved. The recurrence of 
portosystemic encephalopathy was not observed 
and ammonia levels decreased to a range of 60 
to 90 µmol/l. The patient was placed on the wait‑
ing list for kidney transplantation, which will be 
the best treatment option.5
DC
